• Explore /
  • Poster
  • / Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma.

Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma.

Abstract Poster

Authors

Syed Hussain

Syed A. Hussain

Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom

Syed A. Hussain , Nobuaki Shimizu , Wataru Obara , Toshinari Yamasaki , Satoru Takashima , Takahiro Hasegawa , Motofumi Iguchi , Kenji Igarashi , Osamu Ogawa , Tomoaki Fujioka

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

EudraCT 2013-005274-22

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 440)

DOI

10.1200/JCO.2021.39.6_suppl.440

Abstract #

440

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Scott T. Tagawa

First Author: Hiroaki Tanaka

First Author: Masayuki Takeda

First Author: Yoshihiro Yoshitake